Clinical Report: Impact of alpha-lipoic acid on salivary production in patients

Overview

This randomized clinical study evaluates the efficacy of alpha-lipoic acid (ALA) in preserving salivary gland function in patients undergoing radiotherapy for head and neck cancer. Findings indicate that ALA administration significantly improves salivary output compared to placebo, addressing a critical complication of radiotherapy.

Background

Head and neck cancer is a prevalent malignancy that often requires radiotherapy, which can lead to significant adverse effects on salivary glands, resulting in hyposalivation and xerostomia. These conditions severely impact patients' quality of life, making effective management strategies essential. Alpha-lipoic acid, known for its antioxidant properties, may offer a therapeutic approach to mitigate radiation-induced salivary gland damage.

Data Highlights

No numerical data provided in the article.

Key Findings

• Radiotherapy for head and neck cancer commonly leads to hyposalivation and xerostomia.
• Alpha-lipoic acid (ALA) has shown potential in preserving salivary gland function during radiotherapy.
• Patients receiving ALA demonstrated a significant improvement in salivary output compared to those on placebo.
• ALA may protect against radiation-induced acinar cell destruction and promote salivary secretion.
• Further research is needed to establish the long-term efficacy and safety of ALA in this context.

Clinical Implications

The findings suggest that ALA could be a valuable adjunct therapy for patients undergoing radiotherapy for head and neck cancer, potentially alleviating the debilitating effects of xerostomia. Clinicians should consider incorporating ALA into treatment protocols to enhance patient quality of life.

Conclusion

Alpha-lipoic acid shows promise in improving salivary production in patients receiving radiotherapy for head and neck cancer. Further studies are warranted to confirm these findings and explore the broader implications for patient care.

References

1. Kim et al., BMC Cancer, 2026 -- Effect of alpha-lipoic acid on salivary secretion in patients undergoing head and neck radiotherapy
2. the asco post — Small Study Examines Potential of Artificial Saliva in Patients With Head and Neck Cancer
3. The ASCO Post — Acupuncture May Reduce Radiation-Induced Dry Mouth for Patients With Head and Neck Cancer
4. Bone Marrow Transplantation — Alterations in Salivary Composition Associated with Oral Mucositis After Autologous Hematopoietic Stem Cell Transplantation
5. the asco post — Bacterial Decolonization to Manage Acute Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma
6. Small Study Examines Potential of Artificial Saliva in Patients With Head and Neck Cancer
7. Acupuncture May Reduce Radiation-Induced Dry Mouth for Patients With Head and Neck Cancer
8. Alterations in Salivary Composition Associated with Oral Mucositis After Autologous Hematopoietic Stem Cell Transplantation
9. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT)
10. Salivary Gland Hypofunction and/or
11. Effect of alpha-lipoic acid on salivary secretion in patients undergoing head and neck radiotherapy: a randomized clinical trial | BMC Cancer | Springer Nature Link